Triple Electrical Impedance Tomography (EIT) lung imaging in neonates, children, and young adults
Official title: Characterizing the Evolution of Neonatal Lung Disease Throughout Infancy and Childhood Using Electrical Impedance Tomography: A Pilot Study
Run by University of Colorado, Denver · NCT07247474 · Data updated 2026-11-12
This study will try using electrical impedance tomography (EIT) to compare lung images of infants, children, and young adults with cardiopulmonary disease to those without lung disease.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 2 Weeks to 25 Years |
| Sex | All |
| Enrollment | 140 (estimated) |
| Sponsor | University of Colorado, Denver Academic / other |
| Drugs / interventions | radiation |
| Locations | 1 site (Aurora, Colorado) |
| Status | Recruiting |
| Started | January 30, 2026 |
| Main results expected | November 2028 |
| Study ends | December 2028 |
| Registry record updated | February 23, 2026 |
| Trial ID | NCT07247474 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are people aged 2 weeks to 25 years who either have cardiopulmonary disease as listed in the eligibility criteria or are healthy term-born controls with no cardiopulmonary disease.
✕Probably not a fit
Patients younger than 2 weeks, those who cannot have electrodes placed on the chest (for example due to skin problems, large dressings, or multiple chest tubes), people with intrathoracic metal implants like pacemakers, pregnant or lactating patients, and those who do not provide informed consent would not benefit from participation.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study uses non‑ionizing electrical impedance tomography (EIT) to image lung structure and ventilation via chest electrodes, similar to how an EKG reads the heart. Participants aged 2 weeks to 25 years will include those with a range of cardiopulmonary conditions (for example post-prematurity respiratory disease, congenital diaphragmatic hernia, pulmonary hypertension, congenital heart disease, respiratory failure, neuromuscular disease, or developmental lung disorders) and matched healthy term-born controls. Investigators will compare EIT measurements between the disease and control groups to characterize lung composition and ventilation patterns without using CT or X‑ray. Participants with contraindications to electrode placement, pacemakers or other intrathoracic metal implants, pregnancy, or inability to give informed consent will be excluded.
Why it matters
Potential benefit: If successful, this approach could provide a safer, bedside way to better understand and monitor lung structure and function in infants and children without exposure to radiation.
How similar studies have gone: EIT has been used successfully in other neonatal and adult respiratory studies to monitor ventilation distribution, but methods are still being refined and it is not yet standard clinical practice everywhere.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * 2 weeks to 25 years of age * evidence of cardiopulmonary disease including, but not limited to: 1. Post-prematurity respiratory disease 2. Congenital diaphragmatic hernia 3. Pulmonary Hypertension 4. Congenital heart disease 5. Respiratory failure 6. Neuromuscular Disease 7. Developmental or congenital lung disease OR matched healthy controls (born at term gestation (\>36 weeks gestational age) with no cardiopulmonary disease) Exclusion Criteria: * \<2 weeks of age * Anything that interferes with lead placement on the chest wall (such as, dermatologic conditions, multiple chest tubes, anatomic abnormality, or large dressings that cannot be moved) * No informed consent * Pregnant or lactating * Pacemaker or other metal intrathoracic surgical implant (causes noise in the data)
Where it's running
-
Children's Hospital Colorado
Aurora, Colorado, United States Recruiting
Study contacts
- Principal investigator: Katelyn Enzer, MD — University of Colorado, Denver
- Study coordinator: Katelyn Enzer, MD
- Email: allison.keck@childrenscolorado.org
- Phone: 7207779137
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Compare two ventilator modes in adults with cardiac ICU needs and invasive ventilation
This pilot tests whether volume-controlled versus pressure-controlled ventilation can be safely used in adults with heart disease and respiratory failure who need invasive ventilation.
-
Normal lung and heart function references for healthy US veterans who served in Southwest Asia
This study tests whether healthy veterans aged 24–68 who did not have exposure to airborne hazards have normal lung and heart function values that can serve as reference standards.
-
Duration of surfactant administration: 1 minute vs 5 minutes in very preterm babies
This trial tests whether giving surfactant over 1 minute or 5 minutes during the LISA procedure helps stabilize cerebral and overall oxygen levels in extremely preterm infants.
-
Rope skipping to improve heart and lung fitness in children
This trial will test whether regular rope skipping improves heart and lung fitness in 6- to 12-year-old schoolchildren.
-
Functional ultrasound (fUS) for measuring brain connectivity in newborns
This project tests whether a new bedside functional ultrasound (fUS) scan can measure brain connectivity in newborns at high risk of neurodevelopmental problems, including very preterm infants, babies with growth restriction, or those with oxygen injury at birth.
-
Validation of VO2Max Estimation Methods Using Wearable Biosensors
This study is testing if wearable devices can accurately estimate how well your heart and lungs work during daily activities for both healthy people and those getting standard exercise tests.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.